Meeting Details - The shareholders' meeting was held on June 20, 2025, at the company's third-floor conference room [1] - The meeting was convened by the board of directors and chaired by the chairman, utilizing a combination of on-site and online voting methods [1] Voting Results - All proposed resolutions were approved with significant majority votes, including: - First resolution: 1,268,756,206 votes in favor (99.6779%) [1] - Second resolution: 1,268,665,806 votes in favor (99.6708%) [1] - Third resolution: 1,265,970,906 votes in favor (99.4590%) [1] - Fourth resolution: 1,235,870,836 votes in favor (97.0943%) [1] - Fifth resolution: 1,266,313,406 votes in favor (99.4860%) [2] - Additional resolutions also received over 99% approval [2][3] Legal Compliance - The meeting and voting procedures were confirmed to comply with the Company Law, Securities Law, and relevant regulations, ensuring the legality and validity of the resolutions passed [3]
哈药股份: 哈药集团股份有限公司2024年年度股东大会决议公告